These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29665046)

  • 41. [The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].
    Bi CF; Qian HR; Peng LJ; Mao LL; Huang X; Xia DY; Lei X; Qi XK
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):460-5. PubMed ID: 27256609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation.
    Beltrán E; Obermeier B; Moser M; Coret F; Simó-Castelló M; Boscá I; Pérez-Miralles F; Villar LM; Senel M; Tumani H; Hohlfeld R; Casanova B; Dornmair K
    Brain; 2014 Oct; 137(Pt 10):2703-14. PubMed ID: 25060097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis.
    Stauch C; Reiber H; Rauchenzauner M; Strasak A; Pohl D; Hanefeld F; Gärtner J; Rostásy KM
    Mult Scler; 2011 Mar; 17(3):327-34. PubMed ID: 21123302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis.
    Freedman MS; Metzig C; Kappos L; Polman CH; Edan G; Hartung HP; Miller DH; Montalban X; Yarden J; Spector L; Fire E; Dotan N; Schwenke S; Lanius V; Sandbrink R; Pohl C
    Mult Scler; 2012 Jul; 18(7):966-73. PubMed ID: 22183938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review.
    Rahn AC; Köpke S; Stellmann JP; Schiffmann I; Lukas C; Chard D; Heesen C
    Acta Neurol Scand; 2019 Jan; 139(1):18-32. PubMed ID: 30091223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes.
    Runia TF; Jafari N; Hintzen RQ
    Eur J Neurol; 2013 Dec; 20(12):1510-6. PubMed ID: 23906114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis.
    Otto C; Oltmann A; Stein A; Frenzel K; Schroeter J; Habbel P; Gärtner B; Hofmann J; Ruprecht K
    Neurology; 2011 Apr; 76(15):1316-21. PubMed ID: 21482946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnostic value of immunoglobulin free light chains at the debut of multiple sclerosis].
    Nazarov VD; Makshakov GS; Mazing AV; Surkova EA; Krasnov VS; Shumilina MV; Totolyan NA; Evdoshenko EP; Lapin SV; Emanuel VL; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2. Vyp. 2):60-65. PubMed ID: 28617363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurofilament light chain level is a weak risk factor for the development of MS.
    Arrambide G; Espejo C; Eixarch H; Villar LM; Alvarez-Cermeño JC; Picón C; Kuhle J; Disanto G; Kappos L; Sastre-Garriga J; Pareto D; Simon E; Comabella M; Río J; Nos C; Tur C; Castilló J; Vidal-Jordana A; Galán I; Arévalo MJ; Auger C; Rovira A; Montalban X; Tintore M
    Neurology; 2016 Sep; 87(11):1076-84. PubMed ID: 27521440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The natural course of clinically isolated syndrome in pediatric patients.
    Lee CG; Lee B; Lee J; Lee M
    Brain Dev; 2015 Apr; 37(4):432-8. PubMed ID: 25085837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
    Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
    Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study.
    Davies G; Keir G; Thompson EJ; Giovannoni G
    Neurology; 2003 Apr; 60(7):1163-6. PubMed ID: 12682325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.
    Spelman T; Meyniel C; Rojas JI; Lugaresi A; Izquierdo G; Grand'Maison F; Boz C; Alroughani R; Havrdova E; Horakova D; Iuliano G; Duquette P; Terzi M; Grammond P; Hupperts R; Lechner-Scott J; Oreja-Guevara C; Pucci E; Verheul F; Fiol M; Van Pesch V; Cristiano E; Petersen T; Moore F; Kalincik T; Jokubaitis V; Trojano M; Butzkueven H;
    Mult Scler; 2017 Sep; 23(10):1346-1357. PubMed ID: 27885062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Assessment of the risk of the transition of a monofocal clinically isolated syndrome to clinically definite multiple sclerosis].
    Zakharov AV; Khinivtseva EV; Poverennova IE; Gindullina EA; Vlasov IaV; Sineok EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2 Pt 2):28-31. PubMed ID: 23528591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis.
    Baldin E; Riise T; Mattarozzi K; Gajofatto A; Granella F; Leone M; Lugaresi A; Malagù S; Motti L; Neri W; Pesci I; Santangelo M; Scandellari C; Tola MR; Vignatelli L; Zenesini C; D'Alessandro R;
    Neurol Sci; 2019 Jan; 40(1):75-80. PubMed ID: 30255488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis.
    Saveliev AN; Ivanen DR; Kulminskaya AA; Ershova NA; Kanyshkova TG; Buneva VN; Mogelnitskii AS; Doronin BM; Favorova OO; Nevinsky GA; Neustroev KN
    Immunol Lett; 2003 May; 86(3):291-7. PubMed ID: 12706534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of intrathecal IgM synthesis determined by various laboratory methods in patients with early multiple sclerosis - a prospective observational study.
    Revendova K; Zeman D; Kusnierova P; Bunganic R; Hanzlikova P; Karasova K; Volny O; Bar M
    Mult Scler Relat Disord; 2022 Jul; 63():103847. PubMed ID: 35550481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria.
    Habek M; Pavičić T; Ruška B; Pavlović I; Gabelić T; Barun B; Adamec I; Crnošija L; Krbot Skorić M
    Mult Scler Relat Disord; 2018 Oct; 25():99-103. PubMed ID: 30059896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.